Focused Ultrasound: An Emerging Therapeutic Modality for Neurologic Disease

Paul S. Fishman,Victor Frenkel
DOI: https://doi.org/10.1007/s13311-017-0515-1
IF: 6.088
2017-02-27
Neurotherapeutics
Abstract:Therapeutic ultrasound is only beginning to be applied to neurologic conditions, but the potential of this modality for a wide spectrum of brain applications is high. Engineering advances now allow sound waves to be targeted through the skull to a brain region selected with real time magnetic resonance imaging and thermography, using a commercial array of focused emitters. High intensities of sonic energy can create a coagulation lesion similar to that of older radiofrequency stereotactic methods, but without opening the skull. This has led to the recent Food and Drug Administration approval of focused ultrasound (FUS) thalamotomy for unilateral treatment of essential tremor. Clinical studies of stereotactic FUS for aspects of Parkinson’s disease, chronic pain, and refractory psychiatric indications are underway, with promising results. Moderate-intensity FUS has the potential to safely open the blood–brain barrier for localized delivery of therapeutics, while low levels of sonic energy can be used as a form of neuromodulation.
pharmacology & pharmacy,neurosciences,clinical neurology
What problem does this paper attempt to address?
The problems that this paper attempts to solve mainly focus on using focused ultrasound (FUS) as an emerging treatment modality for neurological diseases. Specifically, the paper explores the application potential of FUS in the following aspects: 1. **High - intensity focused ultrasound (HIFU) for stereotactic brain surgery**: Create brain lesions by producing coagulative necrosis to treat movement disorders, such as essential tremor (ET) and Parkinson's disease (PD). This method can achieve a non - invasive or minimally invasive way, reducing the risks and complexity of traditional craniotomy. 2. **Medium - intensity focused ultrasound (FUS) for safely opening the blood - brain barrier (BBB)**: This helps in local drug delivery and improves the treatment effect, especially in tumor treatment. 3. **Low - intensity focused ultrasound (FUS) for neuromodulation**: Affect nerve tissue through mechanical action to stimulate or inhibit neuronal activity, and may be used to treat chronic pain and refractory mental diseases. The paper also discusses the historical background of FUS technology, its operating principles, comparison with existing treatment methods (such as deep brain stimulation, DBS), and its application in clinical trials and potential risks. In conclusion, the paper aims to show the potential of FUS as a safe, effective and widely applicable treatment method for neurological diseases.